547 related articles for article (PubMed ID: 24627566)
1. Prokinetic effects of mirtazapine on gastrointestinal transit.
Yin J; Song J; Lei Y; Xu X; Chen JD
Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G796-801. PubMed ID: 24627566
[TBL] [Abstract][Full Text] [Related]
2. Ameliorating effects of mirtazapine on visceral hypersensitivity in rats with neonatal colon sensitivity.
Yin J; Wang W; Winston JH; Zhang R; Chen JD
Neurogastroenterol Motil; 2010 Sep; 22(9):1022-8, e267. PubMed ID: 20507543
[TBL] [Abstract][Full Text] [Related]
3. Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs.
Onoma M; Yogo K; Ozaki K; Kamei K; Akima M; Koga H; Itoh Z; Omura S; Takanashi H
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):35-42. PubMed ID: 18047625
[TBL] [Abstract][Full Text] [Related]
4. Prostacyclin inhibits gastric emptying and small-intestinal transit in rats and dogs.
Ruwart MJ; Rush BD
Gastroenterology; 1984 Aug; 87(2):392-5. PubMed ID: 6376267
[TBL] [Abstract][Full Text] [Related]
5. Acute and chronic effects of desvenlafaxine on gastrointestinal transit and motility in dogs.
Song J; Yin J; Chen JD
Neurogastroenterol Motil; 2013 Oct; 25(10):824-e637. PubMed ID: 23865827
[TBL] [Abstract][Full Text] [Related]
6. Effect of cyclooxygenase-2 inhibitors on gastric emptying and small intestinal transit in humans.
Bouras EP; Burton DD; Camilleri M; Stephens DA; Thomforde GM
Neurogastroenterol Motil; 2004 Dec; 16(6):729-35. PubMed ID: 15601422
[TBL] [Abstract][Full Text] [Related]
7. Effects of EM574 and cisapride on gastric contractile and emptying activity in normal and drug-induced gastroparesis in dogs.
Tanaka T; Mizumoto A; Mochiki E; Suzuki H; Itoh Z; Omura S
J Pharmacol Exp Ther; 1998 Nov; 287(2):712-9. PubMed ID: 9808701
[TBL] [Abstract][Full Text] [Related]
8. Effect of endotoxin on canine gastrointestinal motility and transit.
Cullen JJ; Caropreso DK; Ephgrave KS
J Surg Res; 1995 Jan; 58(1):90-5. PubMed ID: 7830412
[TBL] [Abstract][Full Text] [Related]
9. [Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma].
Folwaczny C; Läritz M; Meurer M; Endres SP; König A; Schindlbeck N
Z Gastroenterol; 1997 Oct; 35(10):905-12. PubMed ID: 9432812
[TBL] [Abstract][Full Text] [Related]
10. Duodenum electrical stimulation delays gastric emptying, reduces food intake and accelerates small bowel transit in pigs.
Xu X; Lei Y; Chen JD
Obesity (Silver Spring); 2011 Feb; 19(2):442-8. PubMed ID: 20948518
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological basis for the medicinal use of muskmelon base (Pedicellus Melo.) for abdominal distention and constipation.
Gao Y; Cai RL; Xie C; Lin YL; Zhang L; Qi Y
J Ethnopharmacol; 2012 Jun; 142(1):129-35. PubMed ID: 22543170
[TBL] [Abstract][Full Text] [Related]
12. Effect of tegaserod on gut transit in male and female subjects.
Degen L; Petrig C; Studer D; Schroller S; Beglinger C
Neurogastroenterol Motil; 2005 Dec; 17(6):821-6. PubMed ID: 16336497
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of gastric emptying and motility in diabetic gastroparesis with magnetic resonance imaging: effects of cisapride.
Borovicka J; Lehmann R; Kunz P; Fraser R; Kreiss C; Crelier G; Boesiger P; Spinas GA; Fried M; Schwizer W
Am J Gastroenterol; 1999 Oct; 94(10):2866-73. PubMed ID: 10520835
[TBL] [Abstract][Full Text] [Related]
14. Effects of corydaline from Corydalis tuber on gastric motor function in an animal model.
Lee TH; Son M; Kim SY
Biol Pharm Bull; 2010; 33(6):958-62. PubMed ID: 20522959
[TBL] [Abstract][Full Text] [Related]
15. Mitemcinal (GM-611), an orally active motilin receptor agonist, improves delayed gastric emptying in a canine model of diabetic gastroparesis.
Onoma M; Ozaki K; Yogo K; Monnai M; Muramatsu H; Kamei K; Kawabe Y; Hayashi S; Shiga T; Matsuo S; Suzuki M; Itoh Z; Omura S; Takanashi H
Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):788-96. PubMed ID: 18346169
[TBL] [Abstract][Full Text] [Related]
16. Colon electrical stimulation: potential use for treatment of obesity.
Sallam HS; Chen JD
Obesity (Silver Spring); 2011 Sep; 19(9):1761-7. PubMed ID: 21660079
[TBL] [Abstract][Full Text] [Related]
17. Neural gastrointestinal electrical stimulation enhances colonic motility in a chronic canine model of delayed colonic transit.
Sanmiguel CP; Casillas S; Senagore A; Mintchev MP; Soffer EE
Neurogastroenterol Motil; 2006 Aug; 18(8):647-53. PubMed ID: 16918729
[TBL] [Abstract][Full Text] [Related]
18. An orally active motilin receptor antagonist, MA-2029, inhibits motilin-induced gastrointestinal motility, increase in fundic tone, and diarrhea in conscious dogs without affecting gastric emptying.
Ozaki K; Onoma M; Muramatsu H; Sudo H; Yoshida S; Shiokawa R; Yogo K; Kamei K; Cynshi O; Kuromaru O; Peeters TL; Takanashi H
Eur J Pharmacol; 2009 Aug; 615(1-3):185-92. PubMed ID: 19445919
[TBL] [Abstract][Full Text] [Related]
19. Effect of atilmotin on gastrointestinal transit in healthy subjects: a randomized, placebo-controlled study.
Park MI; Ferber I; Camilleri M; Allenby K; Trillo R; Burton D; Zinsmeister AR
Neurogastroenterol Motil; 2006 Jan; 18(1):28-36. PubMed ID: 16371080
[TBL] [Abstract][Full Text] [Related]
20. Comparison of selective M3 and nonselective muscarinic receptor antagonists on gastrointestinal transit and bowel habits in humans.
Bharucha AE; Ravi K; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G215-9. PubMed ID: 20395537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
